European freeze-drying market heats up: Symbiosis invests citing high demand

By Gareth Macdonald

- Last updated on GMT

Symbiosis HQ in Scotland
Symbiosis HQ in Scotland

Related tags Pharmacology

Symbiosis Pharmaceutical Services has launched a bulk freeze drying offering for APIs and intermediates, citing new contracts as a driver for the investment.

The Scotland-based contract manufacturing organisation (CMO) has offered lyophilisation for the sterile filling of vials since its inception.

However, it has now added capacity to provide both aseptic and low bioburden clean room dispensing of bulk materials.

CEO Colin MacKay said: “This service launch has very much been driven by market demand from biotech and pharmaceutical companies requiring either a one-off batch or the ongoing bulk lyophilisation of API or finished product.”

The investment – financial details of which were not disclosed - comes a few months​ after Symbiosis moved to build its presence in the US market, citing the country’s market for injectable drug contracting as a driver.

Freeze drying a hot topic

It also follows hot on the heels of AMRI’s acquisition of an aseptic drug manufacturing facility in Glasgow from Aptuit. The Glasgow site, which houses lyophilisation capabilities, is less than 50 miles away from Symbiosis expanded plant.

Elsewhere in Europe a number of rival contract manufacturing organisations (CMOs) have invested in freeze drying capacity, also citing demand.

Last August​ Carbogen Amcis signed a long-term lease on a facility housing lyophilisation capabilities and Recipharm’s acquisition of Italian contractor Corvette​ was motivated in part by a desire to add such capability.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us


View more